Celldex Therapeutics buy Stifel Nicolaus
Start price
18.06.24
/
50%
€33.20
Target price
18.06.25
€54.03
Performance (%)
-45.18%
End price
19.06.25
€18.20
Summary
This prediction ended on 19.06.25 with a price of €18.20. The BUY prediction by Stifel_Nicolaus for Celldex Therapeutics performed very badly with a performance of -45.18%. Stifel_Nicolaus has a follow-up prediction for Celldex Therapeutics where he still thinks Celldex Therapeutics is a Buy. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Celldex Therapeutics | 3.061% | 3.061% | 40.278% |
| iShares Core DAX® | -2.796% | -1.396% | -0.221% |
| iShares Nasdaq 100 | -6.352% | -0.407% | 28.998% |
| iShares Nikkei 225® | -6.943% | -0.275% | 48.214% |
| iShares S&P 500 | -3.410% | 0.396% | 20.281% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics, Inc. (NASDAQ: CLDX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $58.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
In the thread Trading Celldex Therapeutics
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten
Current prediction by Stifel_Nicolaus for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€26.00
26.02.26
26.02.26
€57.53
26.02.27
26.02.27
-1.35%
08:00
08:00
